← Alle mensen

DM

Daniel M Geynisman

5 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Fase II Trial of Risk-Enabled Therapy After Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer (RETAIN 1).

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 20 maart 2025

Adjuvant pembrolizumab versus observatie bij spierinvasief urotheelcarcinoom: AMBASSADOR fase III

The New England journal of medicine · 2 januari 2025

Enfortumab vedotin met of zonder pembrolizumab bij cisplatine-ineligibel urotheelcarcinoom: EV-103 cohort K

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 1 september 2023

Adjuvant atezolizumab versus observatie bij spierinvasief urotheelcarcinoom: IMvigor010 fase III

The Lancet. Oncology · 2021-04

Onderhoud-pembrolizumab versus placebo na eerstelijns chemotherapie bij urotheelcarcinoom: KEYNOTE-361

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 1 juni 2020